23 August 2018
Pursuant to section 30 of Consolidated Act no. 12 of 8 January 2018 on capital markets, as amended, NeuroSearch A/S ("NeuroSearch") hereby announces to have received a major shareholder announcement from Glaxo Group Limited.
Glaxo Group Limited has informed NeuroSearch that Glaxo Group Limited disposed of all of its shares in NeuroSearch following which Glaxo Group Limited does not hold any shares or voting rights in NeuroSearch.
Allan Andersen, CEO, mobile telephone 4016 3864.
NeuroSearch A/S (NEUR) is listed on Nasdaq Copenhagen A/S.